NCT03023202View on ClinicalTrials.gov

UWCCC Molecular Tumor Board Registry

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

March 30, 2016

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Hematologic NeoplasmsSolid Neoplasm
Interventions
OTHER

PMMTB (Precision Medicine Molecular Tumor Board)

PMMTB is a clinical intervention, NOT a research intervention. The research component of this study is to observe the outcomes of the PMMTB.

Trial Locations (1)

53792

RECRUITING

University of Wisconsin Carbone Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER